Zika Virus: Immunity and Vaccine Development.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27693357.
- Also identified by DOI 10.1016/j.cell.2016.09.020 and PMC identifier 5074878.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The emergence of Zika virus in the Americas and Caribbean created an urgent need for vaccines to reduce transmission and prevent disease, particularly the devastating neurodevelopmental defects that occur in utero. Rapid advances in Zika immunity and the development of vaccine candidates provide cautious optimism that preventive measures are possible.
Medical subject headings
- Viral Vaccines
- Zika Virus
- Zika Virus Infection